Wellness company providing solutions to deliver psychedelic-assisted therapy and transform the mental health landscape Numinus Wellness Inc. (CVE: NUMI) announced having filed a provisional patent application for a psychedelic fungi extraction process.
This is the first patent application the Vancouver based company has announced publicly.
The company says this process dramatically increases the production of therapeutics for use in psychedelics-assisted psychotherapy.
Currently, multiple psychedelics companies are working on psilocybin cultivation and extraction processes. Just to mention a few, they include Havn Life Sciences, Field Trip, Nextleaf, Mydecine and Mimosa Therapeutics.
